Course Content
🫁 Theme I β€” Pain and Fatigue
🫁 Theme II β€” Trauma and Repair
Infection & Inflammation (Foundation II) Module β€” 3rd Year MBBS
AIM β€’ KMU EXAM REASONING

KMU Past Paper Practice

Topic 14 β€” Tetracyclines and Aminoglycosides

3rd Year MBBS β€’ Pharmacology β€’ 20 A-Type Single Best Answer MCQs

Curriculum coverage based on supplied Topic 14 learning outcomes. :contentReference[oaicite:0]{index=0}

MCQ 1

Question:

A 28-year-old man is prescribed a tetracycline-class drug that has a long duration of action and is suitable for convenient oral therapy. Which drug best fits this pharmacological classification?

Options:

Tetracycline
Demeclocycline
Doxycycline
Gentamicin
Neomycin
Correct Answer: Doxycycline
Explanation: Doxycycline is a long-acting tetracycline. Tetracycline is shorter acting, while demeclocycline has an intermediate duration of action.

MCQ 2

Question:

A laboratory compares the effect of two 30S ribosomal inhibitors. Drug X suppresses multiplication without extensive bacterial death, whereas Drug Y rapidly kills susceptible organisms. Which difference best accounts for these observations?

Options:

Drug X blocks cell-wall synthesis while Drug Y blocks folate synthesis
Drug X binds 50S while Drug Y binds bacterial DNA gyrase
Drug X disrupts membranes while Drug Y prevents RNA transcription
Drug X reversibly inhibits translation while Drug Y causes faulty protein synthesis
Drug X inhibits DNA replication while Drug Y inhibits peptidoglycan formation
Correct Answer: Drug X reversibly inhibits translation while Drug Y causes faulty protein synthesis
Explanation: Tetracyclines reversibly inhibit protein-chain elongation and are mainly bacteriostatic, whereas aminoglycosides cause abnormal protein synthesis and bactericidal injury.

MCQ 3

Question:

A student classifies antibacterial protein-synthesis inhibitors according to their principal ribosomal target. Which group contains drugs acting predominantly on the 50S rather than the 30S subunit?

Options:

Tetracyclines and aminoglycosides
Gentamicin and doxycycline
Amikacin and minocycline
Streptomycin and tetracycline
Macrolides and chloramphenicol
Correct Answer: Macrolides and chloramphenicol
Explanation: Macrolides and chloramphenicol are 50S inhibitors. Tetracyclines and aminoglycosides principally target the bacterial 30S subunit.

MCQ 4

Question:

A patient taking an oral tetracycline separates the medicine from his antacid but continues taking it with an iron preparation. His antibacterial response remains suboptimal. Which additional substance would be expected to produce a similar pharmacokinetic problem?

Options:

Calcium-containing dairy product
Simple carbohydrate solution
Water-soluble vitamin preparation
Oral glucose preparation
Sodium chloride solution
Correct Answer: Calcium-containing dairy product
Explanation: Calcium, like iron, can form poorly absorbed complexes with tetracyclines. The shared mechanism is interaction with multivalent metal ions in the gut.

MCQ 5

Question:

A 21-year-old woman taking minocycline for acne reports dizziness and a sensation that the room is moving. Her hearing is preserved and serum creatinine is normal. Which characteristic adverse effect best accounts for her symptoms?

Options:

Proximal tubular dysfunction
Neuromuscular transmission failure
Vestibular disturbance
Bone marrow suppression
Glomerular inflammation
Correct Answer: Vestibular disturbance
Explanation: Minocycline is particularly associated with vestibular adverse effects such as dizziness, vertigo and impaired balance.

MCQ 6

Question:

A patient develops painful swallowing shortly after starting doxycycline. He reports taking the tablet immediately before lying down at night. Which adverse effect most appropriately explains this presentation?

Options:

Drug-induced pancreatitis
Medication-related esophageal irritation
Acute vestibular toxicity
Renal tubular dysfunction
Neuromuscular blockade
Correct Answer: Medication-related esophageal irritation
Explanation: Doxycycline can irritate the esophageal mucosa when a tablet remains in prolonged contact with it, producing painful swallowing or esophagitis.

MCQ 7

Question:

Two bacterial strains are exposed to the same concentration of tetracycline. Both accumulate similar intracellular drug levels, but one strain continues protein synthesis because the drug can no longer effectively interfere with ribosomal function. Which resistance mechanism best explains this finding?

Options:

Increased renal elimination
Reduced gastrointestinal absorption
Enhanced oxygen-dependent uptake
Ribosomal protection
Increased cell-wall permeability
Correct Answer: Ribosomal protection
Explanation: Ribosomal protection proteins allow translation to continue despite adequate intracellular tetracycline, distinguishing this mechanism from reduced entry or efflux.

MCQ 8

Question:

A patient treated with a tetracycline has an infection caused by an organism that lacks a typical extracellular lifestyle and survives within host cells. Which additional pathogen group would be expected to share clinically useful susceptibility to this drug class?

Options:

Dermatophytes
Enteric viruses
Chlamydiae
Candida species
Protozoal parasites
Correct Answer: Chlamydiae
Explanation: Tetracyclines have important activity against atypical and intracellular bacteria, including chlamydiae as well as rickettsiae.

MCQ 9

Question:

A child is inadvertently exposed to repeated tetracycline therapy while permanent teeth are developing. Several years later, dental examination shows a persistent cosmetic abnormality. Which pharmacological property is responsible?

Options:

Inhibition of salivary secretion
Accumulation in calcifying tissues
Blockade of enamel protein synthesis
Suppression of oral bacterial flora
Reduction of gingival blood flow
Correct Answer: Accumulation in calcifying tissues
Explanation: Tetracyclines bind calcium and become incorporated into developing teeth, producing persistent yellow-brown discoloration.

MCQ 10

Question:

A microbiologist observes that an aminoglycoside-treated bacterium produces abnormal proteins and subsequently develops progressive membrane dysfunction. Which initial molecular event most directly leads to this sequence?

Options:

Inhibition of peptidoglycan cross-linking
Blockade of bacterial DNA gyrase
Inhibition of folate metabolism
Suppression of RNA polymerase
Irreversible interference with 30S ribosomal function
Correct Answer: Irreversible interference with 30S ribosomal function
Explanation: Aminoglycosides bind the 30S subunit irreversibly, disturb initiation and translation accuracy, and generate abnormal proteins that contribute to bactericidal membrane injury.

MCQ 11

Question:

An aminoglycoside-resistant Gram-negative isolate has no detectable drug-modifying enzymes. Drug binding to isolated ribosomes is normal, but intact bacteria accumulate very little antibiotic. Which mechanism best accounts for resistance?

Options:

Enhanced intracellular metabolism
Increased ribosomal production
Reduced bacterial uptake
Accelerated peptide elongation
Increased folate production
Correct Answer: Reduced bacterial uptake
Explanation: Reduced entry can cause aminoglycoside resistance even when the ribosomal target remains susceptible and drug-modifying enzymes are absent.

MCQ 12

Question:

A patient with severe infection receives an aminoglycoside. The drug reaches adequate serum concentrations but achieves poor concentrations in cerebrospinal fluid. Which pharmacokinetic characteristic best explains this finding?

Options:

Extensive hepatic metabolism
Rapid intestinal degradation
High intracellular sequestration
Predominant biliary elimination
Limited penetration across tissue barriers
Correct Answer: Limited penetration across tissue barriers
Explanation: Aminoglycosides are highly polar and distribute mainly in extracellular fluid, with poor penetration into sites such as cerebrospinal fluid.

MCQ 13

Question:

A clinician selects tobramycin for a serious infection after culture demonstrates a susceptible aerobic Gram-negative bacillus. Which organism characteristic is most important for effective intracellular delivery of this drug?

Options:

Presence of a polysaccharide capsule
Active oxygen-dependent transport
Production of extracellular enzymes
Formation of bacterial endospores
Presence of intracellular inclusions
Correct Answer: Active oxygen-dependent transport
Explanation: Aminoglycoside uptake across the bacterial cytoplasmic membrane requires oxygen-dependent transport, explaining their activity against aerobic rather than anaerobic organisms.

MCQ 14

Question:

A patient receiving amikacin develops an increase in serum creatinine during therapy. The drug is stopped and renal function subsequently improves. Which site of drug accumulation most directly explains this toxicity?

Options:

Renal tubular cells
Glomerular capillary endothelium
Collecting-duct interstitium
Renal arterial smooth muscle
Glomerular basement membrane
Correct Answer: Renal tubular cells
Explanation: Aminoglycosides accumulate in renal tubular cells and can cause tubular injury, producing the characteristic nephrotoxicity of this drug class.

MCQ 15

Question:

An aminoglycoside-treated patient develops tinnitus. Review of his medication chart identifies a second drug with known ototoxic potential. Which principle best explains why this combination is concerning?

Options:

The second drug prevents gastrointestinal absorption
Both drugs increase tetracycline chelation
Combined exposure can enhance inner-ear toxicity
The second drug converts aminoglycosides to active metabolites
Both drugs competitively block the 50S ribosome
Correct Answer: Combined exposure can enhance inner-ear toxicity
Explanation: Coadministration of another ototoxic drug can increase the risk of aminoglycoside-related cochlear or vestibular damage.

MCQ 16

Question:

Two aminoglycoside regimens produce similar total drug exposure. Regimen X achieves a higher peak concentration, while Regimen Y maintains lower concentrations for a longer period. The organism is susceptible to both. Which regimen characteristic is expected to favor greater initial bacterial killing?

Options:

Longer gastrointestinal residence time
Greater duration below the MIC
Lower extracellular distribution
Higher peak drug concentration
Greater hepatic drug metabolism
Correct Answer: Higher peak drug concentration
Explanation: Aminoglycosides show concentration-dependent killing, so a higher effective peak concentration produces greater initial bactericidal activity.

MCQ 17

Question:

A patient with a susceptible infection receives an aminoglycoside. Several hours after serum concentrations fall substantially, bacterial multiplication remains suppressed. Which additional pharmacodynamic property works together with concentration-dependent killing to produce this prolonged effect?

Options:

Persistent suppression after drug exposure
Extensive enterohepatic recirculation
Progressive hepatic bioactivation
Delayed gastrointestinal absorption
Irreversible plasma protein binding
Correct Answer: Persistent suppression after drug exposure
Explanation: The post-antibiotic effect means bacterial growth remains suppressed after effective drug concentrations decline, complementing concentration-dependent killing.

MCQ 18

Question:

A patient has a localized condition for which an aminoglycoside is desired without significant systemic exposure. The clinician selects a drug whose systemic toxicity limits parenteral use and which is therefore mainly used for local or non-systemic purposes. Which drug is most appropriate?

Options:

Gentamicin
Amikacin
Tobramycin
Streptomycin
Neomycin
Correct Answer: Neomycin
Explanation: Neomycin has important systemic toxicity and is therefore mainly used for local or other non-systemic purposes rather than routine parenteral therapy.

MCQ 19

Question:

A patient with a susceptible serious bacterial infection receives a beta-lactam together with an aminoglycoside. Laboratory testing demonstrates substantially greater killing with the combination. Which sequence best explains the enhanced effect?

Options:

Ribosomal inhibition β†’ increased beta-lactam absorption β†’ enhanced killing
Cell-wall injury β†’ improved aminoglycoside entry β†’ enhanced killing
Renal retention β†’ reduced bacterial uptake β†’ enhanced killing
Chelate formation β†’ increased drug absorption β†’ enhanced killing
Hepatic activation β†’ increased ribosomal binding β†’ enhanced killing
Correct Answer: Cell-wall injury β†’ improved aminoglycoside entry β†’ enhanced killing
Explanation: A cell-wall-active drug can facilitate aminoglycoside penetration into susceptible bacteria, producing synergistic antibacterial killing.

MCQ 20

Question:

A patient receiving an aminoglycoside has stable antibacterial response initially. Renal function then deteriorates, but the treatment exposure is not adjusted. Which sequence best predicts the resulting pharmacological problem?

Options:

Reduced absorption β†’ lower concentration β†’ therapeutic failure
Increased metabolism β†’ lower concentration β†’ reduced toxicity
Increased biliary clearance β†’ lower concentration β†’ therapeutic failure
Reduced renal clearance β†’ drug accumulation β†’ greater toxicity
Increased protein binding β†’ reduced distribution β†’ lower toxicity
Correct Answer: Reduced renal clearance β†’ drug accumulation β†’ greater toxicity
Explanation: Aminoglycosides are eliminated mainly by glomerular filtration. Declining renal function reduces clearance, allowing accumulation and increasing nephrotoxic and ototoxic risk.
Scroll to Top
πŸ’¬ WhatsApp Support